Comments on article by Tran and colleagues, 'double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders' (Multiple letters) [4]

Journal of Clinical Psychopharmacology

Volumn 18, Issue 2, 1998, Pages 174-179

  Schooler, N R ^a   Tollefson, G D ^a   Tran, P V ^a   Gheuens, J ^a   Grebb, J A ^a  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; RISPERIDONE;

CLINICAL TRIAL; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPERPROLACTINEMIA; LETTER; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SYMPTOM; TREATMENT OUTCOME; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; HUMANS; PIRENZEPINE; PSYCHOTIC DISORDERS; RISPERIDONE; SCHIZOPHRENIA;

EID: 0031923236     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199804000-00013     Document Type: Letter

References (0)